Ask AI
ProCE Banner Activity

Management of PBC With Suboptimal Biochemical Response

Slideset

Use these slides to learn about the treatment options for people with PBC who do not have an adequate biochemical response to first-line therapy. 

Released: December 30, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This activity is intended for physicians, including hepatologists and gastroenterologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals involved in the care of patients with PBC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Create personalized therapeutic plans for patients with PBC who do not have an adequate biochemical response to first-line therapy

Disclosure

Primary Author

Mark Swain, MD, MSc, FRCPC, FAASLD, FCAHS: consultant/advisor/speaker: Abbott, Advanz, Boehringer Ingelheim, Gilead, GSK, Ipsen, Mirum, Novo Nordisk, Umecrine; researcher: 89Bio, Altimmune, Ancella, Boehringer Ingelheim, CymaBay, Galectin, Gilead, GSK, Inventiva, Ipsen, Kowa, Lilly, Madrigal, Merck, Mirum, Novo Nordisk, Pfizer, Roche.